Michael Platten, MD
banner
michael-platten.bsky.social
Michael Platten, MD
@michael-platten.bsky.social
Neurologist, Chair of Neurology
Brain Tumor Immunotherapy
@dkfz.bsky.social
@platten-lab.bsky.social
@uniheidelberg.bsky.social
Medical Faculty Mannheim
Founder Tcelltech
President @eanoassociation.bsky.social
Ambassador for the @erc.europa.eu
Excited to announce that we have completed accrual of the INTERCEPT-H3 trial (NCT04808245). This phase 1 first-in-human trial explores safety and immunogenicity of a long peptide vaccine targeting the clonal driver mutation H3K27M in adult patients with newly diagnosed diffuse midline gliomas 1/
July 29, 2025 at 12:35 PM
Our very own outstanding MD student Kuralay Aman @platten-lab.bsky.social @dkfz.bsky.social received the @daadworldwide.bsky.social Award for International Students at Heidelberg University not only for her fantastic work on brain tumor immunotherapy but also for her societal engagement. Brava!
February 6, 2025 at 8:32 PM
It's a wrap for Dr. Dennis Agardy @platten-lab.bsky.social - outstanding PhD thesis defense - well deserved celebration - so glad he'll stay for a postdoc for two more years.
December 5, 2024 at 7:02 PM
Fantastic Grand Round by Francisco Quintana @harvardmed.bsky.social here at the Medical Facultx Mannheim, Heidelberg University. Great discussions, many new ideas exchanged on CNS immunity. @researchlifesci.bsky.social @neurooncologyhd.bsky.social
November 28, 2024 at 5:22 PM
My first post on Bluesky to celebrate 2 full days of science on #glioblastoma (No stone left unturned) with great discussions with outstanding friends and scientists and many new ideas. Many thanks to the Mark and Sontag Foundations.
November 16, 2024 at 10:05 PM